Flavone C-Glycosides from Dianthus superbus L. Attenuate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) via Multi-Pathway Regulations
Nutrients · 2025
DOI: 10.3390/nu17152456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Ming Chu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China. Hauptthemen laut MEDLINE: Glycosides, Flavones, Fatty Liver. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Natural Science Foundation, China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The metabolic dysfunction-associated steatotic liver disease (MASLD) represents an escalating global health concern, with effective treatments still lacking. Given its complex pathogenesis, multi-targeted strategies are highly desirable.
Methods
This study reports the isolation of four flavone C-glycosides (FCGs) from Dianthus superbus L. and explores their potential in treating MASLD. The bioactivity and underlying mechanisms of FCGs were systematically evaluated by integrating network pharmacology, molecular docking, and zebrafish model validation.
Results
Network pharmacology analysis revealed that FCGs may modulate multiple MASLD-related pathways, including lipid metabolism, insulin signaling, inflammation, and apoptosis. Molecular docking further confirmed strong binding affinities between FCGs and key protein targets involved in these pathways. In the zebrafish model of MASLD induced by egg yolk powder, FCGs administration markedly attenuated obesity, hepatic lipid accumulation, and liver tissue damage. Furthermore, FCGs improved lipid metabolism and restored locomotor function. Molecular analyses confirmed that FCGs upregulated PPARγ expression to promote lipid metabolism, restored insulin signaling by enhancing INSR, PI3K, and AKT expression, and suppressed inflammation by downregulating TNF, IL-6 and NF-κB. Additionally, FCGs inhibited hepatocyte apoptosis by elevating the BCL-2/BAX ratio.
Conclusions
These findings highlight the multi-pathway regulatory effects of FCGs in MASLD, underscoring its potential as a novel therapeutic candidate for further preclinical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Mitochondria and Healthy Aging, College of Life Sciences, Yantai University, Yantai 264005, China.
- Qinghai Provincial Key Laboratory of Tibetan Medicine Research, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining 810001, China.
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing 210023, China.
Förderung
- Shandong Provincial Natural Science Foundation, China
- National Natural Science Foundation of China
Zitieren
APA
Chu, M., Tong, Y., Zhang, L., Zhang, Y., Dang, J., & Li, G. (2025). Flavone C-Glycosides from Dianthus superbus L. Attenuate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) via Multi-Pathway Regulations. Nutrients. https://doi.org/10.3390/nu17152456
Vancouver
Chu M, Tong Y, Zhang L, Zhang Y, Dang J, Li G. Flavone C-Glycosides from Dianthus superbus L. Attenuate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) via Multi-Pathway Regulations. Nutrients. 2025. doi:10.3390/nu17152456
BibTeX
@article{Chu2025,
author = {Chu, Ming and Tong, Yingying and Zhang, Lei and Zhang, Yu and Dang, Jun and Li, Gang},
title = {Flavone C-Glycosides from Dianthus superbus L. Attenuate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) via Multi-Pathway Regulations},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17152456}
}
EUVIMED